#AACR2026: First‑in‑Human STC‑1010 data show favorable safety and early immune engagement in metastatic MSS colorectal cancer
Brenus Pharma reports favorable tolerability and clinical signals in early preliminary results of first-in-human study for STC-1010 in unresectable metastatic stage MSS CRC patients
